IP Library › Granted Patent US 11,942,202
Granted Patent B2
US 11,942,202 · App. 17/403,518 · Granted Mar 26, 2024

Burden-free blood glucose management for insulin-requiring diabetes with minimal user interaction

Inventor: Lane Desborough (Thousand Oaks, CA)
Assignee: Nudge BG, Inc.
G16H20/17A61M5/14248A61M5/1723G05B23/0272G16H40/40G16H40/67A61M2205/18A61M2205/3584A61M2205/502A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,942,202
App. No.
17/403,518
Granted
Mar 26, 2024
Kind
B2
Abstract

Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.

Claims (37)

1. A method comprising:

receiving previous insulin delivery data at a user device from an insulin pump;

receiving at the user device estimated glucose data from a continuous glucose monitor;

determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data;

communicating instructions to an insulin pump to deliver the insulin delivery amount; and

not providing data representative of the estimated glucose data or the insulin delivery data to a user through a user interface of the user device.

2. The method according to claim 1 , wherein determining the insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount to bring the estimated glucose data closer to a target glucose value.

3. The method according to claim 2 , wherein determining the insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount without using any user-specific behavioral data physically entered by a user through a user interface of a device within a previous period of time.

4. The method according to claim 3 , wherein the previous period of time is less than 6 hours.

5. The method according to claim 1 , wherein the user interface is part a mobile device.

6. The method according to claim 1 , further comprising determining an insulin delivery amount and communicating the insulin delivery amount to the insulin pump.

7. A non-transitory computer-readable medium storing instructions that, when executed by a mobile computing device, cause the mobile computing device to:

receive at the computing device estimated glucose data from a continuous glucose monitor;

determine at the computing device that the estimated glucose value is approaching or has passed a threshold;

determine an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data;

communicate instructions to an insulin pump to deliver the insulin delivery amount; and

not provide an indication to the user through a user interface of the computing device that the estimated glucose value is approaching or surpassed the threshold.

8. The non-transitory computer-readable medium according to claim 7 , wherein determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount to bring the estimated glucose data closer to a target glucose value.

9. The non-transitory computer-readable medium according to claim 7 , wherein determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount without using user-specific data that is physically entered by a user through a user interface of the mobile computing device within the previous period of time.

10. The non-transitory computer-readable medium according to claim 9 , wherein the previous period of time is less than 6 hours.

11. The non-transitory computer-readable medium according to claim 9 , wherein the previous period of time is less than 120 minutes.

12. The non-transitory computer-readable medium according to claim 7 , wherein the indication is an alarm or an alert.

13. A method comprising:

receiving previous insulin delivery data at a user device from an insulin pump;

receiving at the user device estimated glucose data from a continuous glucose monitor;

determining at the user device either or both a glucose trend or a glucose pattern; and

in response to determining either or both the glucose trend or the glucose pattern, not displaying an indication of the trend or the pattern to a user through a user interface of the user device.

14. The method according to claim 13 , wherein determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount to bring the estimated glucose data closer to a target glucose value.

15. The method according to claim 13 , wherein determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data includes determining the insulin delivery amount without using any user-specific behavioral data physically entered by a user through a user interface of a device within a previous period of time.

16. The method according to claim 15 , wherein the previous period of time is less than 6 hours.

17. The method according to claim 16 , wherein the either or both a glucose trend or a glucose pattern comprises a prediction of future estimated glucose in the user's blood.

18. The method according to claim 17 , wherein the either or both a glucose trend or a glucose pattern comprises one of increasing glucose levels or decreasing glucose levels.

19. The method according to claim 13 , wherein the indication comprise an indication selected from the group consisting of:

a graphical representation of the trend or the pattern; and

an alert or an alarm.

20. The method according to claim 13 , wherein the user interface is part of a mobile device.

21. The method according to claim 13 , wherein the user device and the insulin pump comprise a single device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2021
From: DESBOROUGH, LANE
To: NUDGE BG, INC.
Reel/Frame 057195/0085 →
Continuity (4)
Continuation 17149598 · Jan 14, 2021
Provisional Application 62962178 · Jan 16, 2020
Provisional Application 62962179 · Jan 16, 2020
Related Publication 20210375422A1 · Dec 2, 2021
Cited By (3)
US 12,237,063 US 12,283,361 US 12,308,103